Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area

Yukari Fujita, Junji Kozawa, Hiromi Iwahashi, Syo Yoneda, Sae Uno, Atsushi Yoshikawa, Kohei Okita, Hidetoshi Eguchi, Hiroaki Nagano, Akihisa Imagawa, Iichiro Shimomura

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Pancreatic beta-cell mass contributes to glucose tolerance. The aim of this study was to evaluate the relationships between human beta-cell mass and various clinical parameters, including insulin secretory capacity. The study included 32 Japanese patients who underwent pancreatectomy and were naive to oral hypoglycemic agents and insulin. They were classified into those with normal glucose tolerance (n=13), impaired glucose tolerance (n=9) and diabetes (n=10), and their insulin secretory capacity and insulin resistance were evaluated. Immunohistochemistry was used to determine relative beta-cell area (%) which represented the proportion of insulin-positive cell area to whole pancreatic section. Increment of C-peptide immunoreactivity level by glucagon test (ΔC-peptide, increment of serum C-peptide [nmol/L] at 6 min after intravenous injection of 1-mg glucagon; r=0.64, p=0.002), homeostasis model assessment of beta-cell function (HOMAbeta, fasting immunoreactive insulin [µIU/mL] x 20 / (fasting plasma glucose [mmol/L] – 3.5); r=0.50, p=0.003), C-peptide index (CPI, fasting C-peptide [nmol/L] / fasting plasma glucose [mmol/L]; r=0.36, p=0.042), and fasting immunoreactive insulin (F-IRI [pmol/L]; r=0.36, p=0.044) correlated significantly and positively with the relative beta-cell area. The area under the curve of plasma glucose level from 0 to 120 min by 75 g-OGTT (AUC0-120) also correlated significantly and inversely with the relative beta-cell area (r=–0.36, p=0.045). Stepwise multiple regression analysis identified ΔC-peptide as the only independent and significant determinant of the relative beta-cell area. We conclude that ΔC-peptide, HOMAbeta, CPI, F-IRI and AUC0-120 correlated closely with the relative beta-cell area, and ΔC-peptide was the most valuable index for the prediction of the area.

Original languageEnglish
Pages (from-to)329-337
Number of pages9
JournalEndocrine Journal
Volume62
Issue number4
DOIs
Publication statusPublished - Jan 1 2015

Fingerprint

C-Peptide
Glucagon
Fasting
Insulin
Serum
Glucose
Pancreatectomy
Glucose Intolerance
Insulin-Secreting Cells
Glucose Tolerance Test
Hypoglycemic Agents
Intravenous Injections
Area Under Curve
Insulin Resistance
Homeostasis
Immunohistochemistry
Regression Analysis

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Fujita, Y., Kozawa, J., Iwahashi, H., Yoneda, S., Uno, S., Yoshikawa, A., ... Shimomura, I. (2015). Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area. Endocrine Journal, 62(4), 329-337. https://doi.org/10.1507/endocrj.EJ14-0456

Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area. / Fujita, Yukari; Kozawa, Junji; Iwahashi, Hiromi; Yoneda, Syo; Uno, Sae; Yoshikawa, Atsushi; Okita, Kohei; Eguchi, Hidetoshi; Nagano, Hiroaki; Imagawa, Akihisa; Shimomura, Iichiro.

In: Endocrine Journal, Vol. 62, No. 4, 01.01.2015, p. 329-337.

Research output: Contribution to journalArticle

Fujita, Y, Kozawa, J, Iwahashi, H, Yoneda, S, Uno, S, Yoshikawa, A, Okita, K, Eguchi, H, Nagano, H, Imagawa, A & Shimomura, I 2015, 'Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area', Endocrine Journal, vol. 62, no. 4, pp. 329-337. https://doi.org/10.1507/endocrj.EJ14-0456
Fujita, Yukari ; Kozawa, Junji ; Iwahashi, Hiromi ; Yoneda, Syo ; Uno, Sae ; Yoshikawa, Atsushi ; Okita, Kohei ; Eguchi, Hidetoshi ; Nagano, Hiroaki ; Imagawa, Akihisa ; Shimomura, Iichiro. / Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area. In: Endocrine Journal. 2015 ; Vol. 62, No. 4. pp. 329-337.
@article{b3720371f8404e1cadd0f7e2528ca7c6,
title = "Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area",
abstract = "Pancreatic beta-cell mass contributes to glucose tolerance. The aim of this study was to evaluate the relationships between human beta-cell mass and various clinical parameters, including insulin secretory capacity. The study included 32 Japanese patients who underwent pancreatectomy and were naive to oral hypoglycemic agents and insulin. They were classified into those with normal glucose tolerance (n=13), impaired glucose tolerance (n=9) and diabetes (n=10), and their insulin secretory capacity and insulin resistance were evaluated. Immunohistochemistry was used to determine relative beta-cell area ({\%}) which represented the proportion of insulin-positive cell area to whole pancreatic section. Increment of C-peptide immunoreactivity level by glucagon test (ΔC-peptide, increment of serum C-peptide [nmol/L] at 6 min after intravenous injection of 1-mg glucagon; r=0.64, p=0.002), homeostasis model assessment of beta-cell function (HOMAbeta, fasting immunoreactive insulin [µIU/mL] x 20 / (fasting plasma glucose [mmol/L] – 3.5); r=0.50, p=0.003), C-peptide index (CPI, fasting C-peptide [nmol/L] / fasting plasma glucose [mmol/L]; r=0.36, p=0.042), and fasting immunoreactive insulin (F-IRI [pmol/L]; r=0.36, p=0.044) correlated significantly and positively with the relative beta-cell area. The area under the curve of plasma glucose level from 0 to 120 min by 75 g-OGTT (AUC0-120) also correlated significantly and inversely with the relative beta-cell area (r=–0.36, p=0.045). Stepwise multiple regression analysis identified ΔC-peptide as the only independent and significant determinant of the relative beta-cell area. We conclude that ΔC-peptide, HOMAbeta, CPI, F-IRI and AUC0-120 correlated closely with the relative beta-cell area, and ΔC-peptide was the most valuable index for the prediction of the area.",
author = "Yukari Fujita and Junji Kozawa and Hiromi Iwahashi and Syo Yoneda and Sae Uno and Atsushi Yoshikawa and Kohei Okita and Hidetoshi Eguchi and Hiroaki Nagano and Akihisa Imagawa and Iichiro Shimomura",
year = "2015",
month = "1",
day = "1",
doi = "10.1507/endocrj.EJ14-0456",
language = "English",
volume = "62",
pages = "329--337",
journal = "Endocrine Journal",
issn = "0918-8959",
publisher = "Japan Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area

AU - Fujita, Yukari

AU - Kozawa, Junji

AU - Iwahashi, Hiromi

AU - Yoneda, Syo

AU - Uno, Sae

AU - Yoshikawa, Atsushi

AU - Okita, Kohei

AU - Eguchi, Hidetoshi

AU - Nagano, Hiroaki

AU - Imagawa, Akihisa

AU - Shimomura, Iichiro

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Pancreatic beta-cell mass contributes to glucose tolerance. The aim of this study was to evaluate the relationships between human beta-cell mass and various clinical parameters, including insulin secretory capacity. The study included 32 Japanese patients who underwent pancreatectomy and were naive to oral hypoglycemic agents and insulin. They were classified into those with normal glucose tolerance (n=13), impaired glucose tolerance (n=9) and diabetes (n=10), and their insulin secretory capacity and insulin resistance were evaluated. Immunohistochemistry was used to determine relative beta-cell area (%) which represented the proportion of insulin-positive cell area to whole pancreatic section. Increment of C-peptide immunoreactivity level by glucagon test (ΔC-peptide, increment of serum C-peptide [nmol/L] at 6 min after intravenous injection of 1-mg glucagon; r=0.64, p=0.002), homeostasis model assessment of beta-cell function (HOMAbeta, fasting immunoreactive insulin [µIU/mL] x 20 / (fasting plasma glucose [mmol/L] – 3.5); r=0.50, p=0.003), C-peptide index (CPI, fasting C-peptide [nmol/L] / fasting plasma glucose [mmol/L]; r=0.36, p=0.042), and fasting immunoreactive insulin (F-IRI [pmol/L]; r=0.36, p=0.044) correlated significantly and positively with the relative beta-cell area. The area under the curve of plasma glucose level from 0 to 120 min by 75 g-OGTT (AUC0-120) also correlated significantly and inversely with the relative beta-cell area (r=–0.36, p=0.045). Stepwise multiple regression analysis identified ΔC-peptide as the only independent and significant determinant of the relative beta-cell area. We conclude that ΔC-peptide, HOMAbeta, CPI, F-IRI and AUC0-120 correlated closely with the relative beta-cell area, and ΔC-peptide was the most valuable index for the prediction of the area.

AB - Pancreatic beta-cell mass contributes to glucose tolerance. The aim of this study was to evaluate the relationships between human beta-cell mass and various clinical parameters, including insulin secretory capacity. The study included 32 Japanese patients who underwent pancreatectomy and were naive to oral hypoglycemic agents and insulin. They were classified into those with normal glucose tolerance (n=13), impaired glucose tolerance (n=9) and diabetes (n=10), and their insulin secretory capacity and insulin resistance were evaluated. Immunohistochemistry was used to determine relative beta-cell area (%) which represented the proportion of insulin-positive cell area to whole pancreatic section. Increment of C-peptide immunoreactivity level by glucagon test (ΔC-peptide, increment of serum C-peptide [nmol/L] at 6 min after intravenous injection of 1-mg glucagon; r=0.64, p=0.002), homeostasis model assessment of beta-cell function (HOMAbeta, fasting immunoreactive insulin [µIU/mL] x 20 / (fasting plasma glucose [mmol/L] – 3.5); r=0.50, p=0.003), C-peptide index (CPI, fasting C-peptide [nmol/L] / fasting plasma glucose [mmol/L]; r=0.36, p=0.042), and fasting immunoreactive insulin (F-IRI [pmol/L]; r=0.36, p=0.044) correlated significantly and positively with the relative beta-cell area. The area under the curve of plasma glucose level from 0 to 120 min by 75 g-OGTT (AUC0-120) also correlated significantly and inversely with the relative beta-cell area (r=–0.36, p=0.045). Stepwise multiple regression analysis identified ΔC-peptide as the only independent and significant determinant of the relative beta-cell area. We conclude that ΔC-peptide, HOMAbeta, CPI, F-IRI and AUC0-120 correlated closely with the relative beta-cell area, and ΔC-peptide was the most valuable index for the prediction of the area.

UR - http://www.scopus.com/inward/record.url?scp=84929456393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929456393&partnerID=8YFLogxK

U2 - 10.1507/endocrj.EJ14-0456

DO - 10.1507/endocrj.EJ14-0456

M3 - Article

C2 - 25740613

AN - SCOPUS:84929456393

VL - 62

SP - 329

EP - 337

JO - Endocrine Journal

JF - Endocrine Journal

SN - 0918-8959

IS - 4

ER -